106 related articles for article (PubMed ID: 23721148)
21. Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status.
Shonka DC; Shoushtari AN; Thomas CY; Moskaluk C; Read PW; Reibel JF; Levine PA; Jameson MJ
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1126-32. PubMed ID: 19917926
[TBL] [Abstract][Full Text] [Related]
22. Impact of Expression of CD44, a Cancer Stem Cell Marker, on the Treatment Outcomes of Intensity Modulated Radiation Therapy in Patients With Oropharyngeal Squamous Cell Carcinoma.
Motegi A; Fujii S; Zenda S; Arahira S; Tahara M; Hayashi R; Akimoto T
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):461-8. PubMed ID: 26867875
[TBL] [Abstract][Full Text] [Related]
23. Asymptomatic p16-positive oropharyngeal squamous cell carcinoma: an emerging trend.
Sand JP; Haughey BH; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2014 Oct; 140(10):975-7. PubMed ID: 25211056
[TBL] [Abstract][Full Text] [Related]
24. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
[TBL] [Abstract][Full Text] [Related]
25. No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression.
Maquieira R; Haerle SK; Huber GF; Soltermann A; Haile SR; Stoeckli SJ; Broglie MA
Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1841-8. PubMed ID: 26059208
[TBL] [Abstract][Full Text] [Related]
26. The dangers of diagnosing cystic neck masses as benign in the era of HPV-associated oropharyngeal cancer.
Wratten C; Anne S; Tieu MT; Kumar B; Eisenberg R
Med J Aust; 2015 Nov; 203(9):371-2. PubMed ID: 26510810
[No Abstract] [Full Text] [Related]
27. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.
McMullen CP; Garneau J; Weimar E; Ali S; Farinhas JM; Yu E; Som PM; Sarta C; Goldstein DP; Su S; Xu W; Smith RV; Miles B; de Almeida JR
Oral Oncol; 2019 Jun; 93():96-100. PubMed ID: 31109703
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of p16
Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
[TBL] [Abstract][Full Text] [Related]
30. The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies.
Langendijk JA; Psyrri A
Ann Oncol; 2010 Oct; 21(10):1931-1934. PubMed ID: 20716626
[No Abstract] [Full Text] [Related]
31. Pre-radiotherapy feeding tube identifies a poor prognostic subset of postoperative p16 positive oropharyngeal carcinoma patients.
Verma V; Liu J; Eschen L; Danieley J; Spencer C; Lewis JS; Diaz J; Piccirillo JF; Adkins DR; Nussenbaum B; Thorstad WL; Gay HA
Radiat Oncol; 2015 Jan; 10():8. PubMed ID: 25572866
[TBL] [Abstract][Full Text] [Related]
32. p16 Expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal cancer.
Chung CH; Raben D
J Clin Oncol; 2010 Sep; 28(27):4103-4. PubMed ID: 20697096
[No Abstract] [Full Text] [Related]
33. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition.
Gurin D; Slavik M; Hermanova M; Shatokhina T; Sana J; Kazda T; Selingerova I; Ahmad P; Smilek P; Horakova Z; Hendrych M; Slampa P; Slaby O
J Oral Pathol Med; 2018 Oct; 47(9):864-872. PubMed ID: 30079604
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of FDG-PET volumetric parameters in patients with p16-positive oropharyngeal squamous cell carcinoma who received curative resection followed by postoperative radiotherapy or chemoradiotherapy.
Kim KH; Lee J; Chang JS; Lee CG; Yun M; Choi EC; Kim SH; Keum KC
Head Neck; 2016 Oct; 38(10):1515-24. PubMed ID: 27062085
[TBL] [Abstract][Full Text] [Related]
36. p16 expression in carcinoma of unknown primary: diagnostic indicator and prognostic marker.
Vent J; Haidle B; Wedemeyer I; Huebbers C; Siefer O; Semrau R; Preuss SF; Klussmann J
Head Neck; 2013 Nov; 35(11):1521-6. PubMed ID: 23345170
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of a 15-gene hypoxia classifier in oropharyngeal cancer treated with accelerated chemoradiotherapy.
Deschuymer S; Sørensen BS; Dok R; Laenen A; Hauben E; Overgaard J; Nuyts S
Strahlenther Onkol; 2020 Jun; 196(6):552-560. PubMed ID: 32080773
[TBL] [Abstract][Full Text] [Related]
38. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
40. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
